Suppr超能文献

直径≤1厘米的甲状腺结节与甲状腺微小乳头状癌:巴西专家意见

Thyroid nodules ≤ 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinion.

作者信息

Rosario Pedro Weslley, Ward Laura Sterian, Graf Hans, Vaisman Fernanda, Mourão Gabriela Franco, Vaisman Mario

机构信息

Santa Casa de Belo Horizonte, Minas Gerais, MG, Brasil.

Faculdade de Ciências Médicas da Universidade Estadual de Campinas (Unicamp), São Paulo, SP, Brasil.

出版信息

Arch Endocrinol Metab. 2019 Sep 2;63(5):456-461. doi: 10.20945/2359-3997000000166. eCollection 2019.

Abstract

The indolent evolution of low-risk papillary thyroid microcarcinoma (mPTC) in adult patients and the consequences of thyroidectomy require a revision of the management traditionally recommended. Aiming to spare patients unnecessary procedures and therapies and to optimize the health system in Brazil, we suggest some measures. Fine-needle aspiration of nodules ≤ 1 cm without extrathyroidal extension on ultrasonography should be performed only in nodules classified as "very suspicious" (i.e., high suspicion according to ATA, high risk according to AACE, TI-RADS 5) and in selected cases [age < 40 years, nodule adjacent to the trachea or recurrent laryngeal nerve (RLN), multiple suspicious nodules, presence of hypercalcitoninemia or suspicious lymph nodes]. Active surveillance (AS) rather than immediate surgery should be considered in adult patients with low-risk mPTC. Lobectomy is the best option in patients with unifocal low-risk mPTC who are not candidates for AS because of age, proximity of the tumor to the trachea or RLN, or because they opted for surgery. The same applies to patients who started AS but had a subsequent surgical indication not due to a suspicion of tumor extension beyond the gland or multicentricity. Molecular tests are not necessary to choose between AS and surgery or, in the latter case, between lobectomy and total thyroidectomy. The presence of RAS or other RAS-like mutations or BRAFV600E or other BRAF V600E-like mutations should not modify the management cited above; however, the rare cases of mPTC exhibiting high-risk mutations, like in the TERT promoter or p53, are not candidates for AS.

摘要

成年患者中低风险甲状腺微小乳头状癌(mPTC)的惰性进展以及甲状腺切除的后果,需要对传统推荐的管理方法进行修订。为了避免患者接受不必要的手术和治疗,并优化巴西的医疗体系,我们提出一些措施。对于超声检查显示直径≤1 cm且无甲状腺外侵犯的结节,仅应对分类为“高度可疑”(即根据美国甲状腺协会为高可疑,根据美国临床内分泌医师协会为高风险,TI-RADS 5类)的结节以及特定情况(年龄<40岁、结节紧邻气管或喉返神经(RLN)、多个可疑结节、存在降钙素血症或可疑淋巴结)进行细针穿刺。对于低风险mPTC的成年患者,应考虑采取主动监测(AS)而非立即手术。对于因年龄、肿瘤与气管或RLN的距离等原因不适合AS或选择手术的单灶低风险mPTC患者,肺叶切除术是最佳选择。对于开始AS但随后出现手术指征(并非怀疑肿瘤超出腺体或多中心性)的患者也是如此。在选择AS与手术之间,或者在后一种情况下,在肺叶切除术与全甲状腺切除术之间,分子检测并非必需。RAS或其他类似RAS的突变、BRAFV600E或其他类似BRAF V600E的突变的存在不应改变上述管理方法;然而,mPTC中表现出高风险突变(如TERT启动子或p53中的突变)的罕见病例不适合AS。

相似文献

1
Thyroid nodules ≤ 1 cm and papillary thyroid microcarcinomas: Brazilian experts opinion.
Arch Endocrinol Metab. 2019 Sep 2;63(5):456-461. doi: 10.20945/2359-3997000000166. eCollection 2019.
6
ACR TI-RADS and ATA US scores are helpful for the management of thyroid nodules with indeterminate cytology.
BMC Endocr Disord. 2019 Oct 29;19(1):112. doi: 10.1186/s12902-019-0429-5.
10
The anteroposterior diameter of nodules in the risk assessment of papillary thyroid microcarcinoma.
Medicine (Baltimore). 2018 Mar;97(10):e9712. doi: 10.1097/MD.0000000000009712.

引用本文的文献

1
2
Impact of a simple informative leaflet on Brazilian doctors' attitudes towards active surveillance of thyroid microcarcinomas.
Heliyon. 2024 Sep 2;10(17):e37300. doi: 10.1016/j.heliyon.2024.e37300. eCollection 2024 Sep 15.
6
Molecular Testing for Thyroid Nodules of Indeterminate Cytology: A Health Technology Assessment.
Ont Health Technol Assess Ser. 2022 Apr 1;22(2):1-111. eCollection 2022.
10
Active surveillance of thyroid microcarcinomas.
Arch Endocrinol Metab. 2019 Oct 10;63(5):454-455. doi: 10.20945/2359-3997000000181. eCollection 2019.

本文引用的文献

1
Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.
Thyroid. 2018 Dec;28(12):1587-1594. doi: 10.1089/thy.2018.0263. Epub 2018 Oct 17.
2
Active Surveillance in Thyroid Microcarcinoma in a Latin-American Cohort.
JAMA Otolaryngol Head Neck Surg. 2018 Oct 1;144(10):947-948. doi: 10.1001/jamaoto.2018.1663.
3
Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies.
J Endocrinol Invest. 2018 Jul;41(7):849-876. doi: 10.1007/s40618-018-0884-2. Epub 2018 May 4.
4
Ultrasound-guided percutaneous microwave ablation versus surgery for papillary thyroid microcarcinoma.
Int J Hyperthermia. 2018 Aug;34(5):653-659. doi: 10.1080/02656736.2018.1453092. Epub 2018 Apr 11.
5
Prediction of Cancer Incidence and Mortality in Korea, 2018.
Cancer Res Treat. 2018 Apr;50(2):317-323. doi: 10.4143/crt.2018.142. Epub 2018 Mar 21.
7
High Serum TSH Level Is Associated With Progression of Papillary Thyroid Microcarcinoma During Active Surveillance.
J Clin Endocrinol Metab. 2018 Feb 1;103(2):446-451. doi: 10.1210/jc.2017-01775.
9
Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.
JAMA Otolaryngol Head Neck Surg. 2017 Oct 1;143(10):1015-1020. doi: 10.1001/jamaoto.2017.1442.
10
Ethanol and thermal ablation for malignant thyroid tumours.
Int J Hyperthermia. 2017 Dec;33(8):938-945. doi: 10.1080/02656736.2017.1361048. Epub 2017 Aug 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验